Commerzbank Aktiengesellschaft’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-16,891
Closed -$1.7M 1269
2014
Q4
$1.7M Buy
16,891
+12,393
+276% +$963K 0.01% 712
2014
Q3
$298K Buy
+4,498
New +$295K ﹤0.01% 1040
2014
Q2
Sell
-9,198
Closed -$673K 1266
2014
Q1
$673K Buy
9,198
+2,824
+44% +$211K ﹤0.01% 916
2013
Q4
$466K Buy
6,374
+407
+7% +$26.3K ﹤0.01% 1074
2013
Q3
$379K Sell
5,967
-1,496
-20% -$90.4K ﹤0.01% 1074
2013
Q2
$360K Buy
+7,463
New +$367K ﹤0.01% 1182

Commerzbank Aktiengesellschaft's CBST Position: Q1 2015 in Review

Commerzbank Aktiengesellschaft sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 16,891 shares — an estimated $1.7M sold.

Commerzbank Aktiengesellschaft first reported a position in CBST in Q2 2013 and held it in 6 quarters. The position peaked at $1.7M in Q4 2014. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

  • Commerzbank Aktiengesellschaft reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 16,891 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $1.7M.
  • Commerzbank Aktiengesellschaft first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 6 quarters.
  • Commerzbank Aktiengesellschaft's CUBIST PHARMACEUTICALS INC position peaked at $1.7M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q1 2015, filed 1 May 2015.